| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |